19952020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Activity and safety of bevacizumab plus fotemustine for recurrent malignant gliomas

Vaccaro, V., Fabi, A., Vidiri, A., Giannarelli, D., Metro, G., Telera, S., Vari, S., Piludu, F., Carosi, M. A., Villani, V., Cognetti, F., Pompili, A., Marucci, L., Carapella, C. M. & Pace, A., 2014, In : BioMed Research International. 2014, 351252.

Research output: Contribution to journalArticle

Activity of Eribulin Mesylate in Brain Metastasis from Breast Cancer: A Stone in a Pond?

Catania, G., Malaguti, P., Gasparro, S., Cognetti, F., Vidiri, A. & Fabi, A., Jul 1 2018, In : Oncology (Switzerland). 94, p. 29-33 5 p.

Research output: Contribution to journalArticle

Addition of either lonidamine or granulocyte colony-stimulating factor does not improve survival in early breast cancer patients treated with high-dose epirubicin and cyclophosphamide

Papaldo, P., Lopez, M., Cortesi, E., Cammilluzzi, E., Antimi, M., Terzoli, E., Lepidini, G., Vici, P., Barone, C., Ferretti, G., Di Cosimo, S., Nisticò, C., Carlini, P., Conti, F., Di Lauro, L., Botti, C., Vitucci, C., Fabi, A., Giannarelli, D. & Marolla, P., Sep 15 2003, In : Journal of Clinical Oncology. 21, 18, p. 3462-3468 7 p.

Research output: Contribution to journalArticle

Adherence to Oral Administration of Endocrine Treatment in Patients with Breast Cancer: A Qualitative Study

Iacorossi, L., Gambalunga, F., Fabi, A., Giannarelli, D., Marchetti, A., Piredda, M. & De Marinis, M. G., Jan 1 2018, In : Cancer Nursing. 41, 1, p. E57-E63

Research output: Contribution to journalArticle

Adherence to Oral Administration of Endocrine Treatment in Patients With Breast Cancer: A Qualitative Study

Iacorossi, L., Gambalunga, F., Fabi, A., Giannarelli, D., Marchetti, A., Piredda, M. & De Marinis, M. G., Dec 5 2016, In : Cancer Nursing.

Research output: Contribution to journalArticle

A divergent role for estrogen receptor-beta in node-positive and node-negative breast cancer classified according to molecular subtypes: An observational prospective study

Novelli, F., Milella, M., Melucci, E., Di Benedetto, A., Sperduti, I., Perrone-Donnorso, R., Perracchio, L., Venturo, I., Nisticò, C., Fabi, A., Buglioni, S., Natali, P. G. & Mottolese, M., Sep 4 2008, In : Breast Cancer Research. 10, 5, R74.

Research output: Contribution to journalArticle

Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial

De Placido, S., Gallo, C., De Laurentiis, M., Bisagni, G., Arpino, G., Sarobba, M. G., Riccardi, F., Russo, A., Del Mastro, L., Cogoni, A. A., Cognetti, F., Gori, S., Foglietta, J., Frassoldati, A., Amoroso, D., Laudadio, L., Moscetti, L., Montemurro, F., Verusio, C., Bernardo, A. & 209 others, Lorusso, V., Gravina, A., Moretti, G., Lauria, R., Lai, A., Mocerino, C., Rizzo, S., Nuzzo, F., Carlini, P., Perrone, F., Accurso, A., Agostara, B., Aieta, M., Alabiso, O., Alicicco, M. G., Amadori, D., Amaducci, L., Amiconi, G., Antuzzi, G., Ardine, M., Ardizzoia, A., Aversa, C., Badalamenti, G., Barni, S., Basurto, C., Berardi, R., Bergamasco, C., Bidoli, P., Bighin, C., Biondi, E., Bisagni, G., Boni, C., Borgonovo, K., Botta, M., Bravi, S., Bruzzi, P., Buono, G., Butera, A., Caldara, A., Candeloro, G., Cappelletti, C., Cardalesi, C., Carfora, E., Cariello, A., Carrozza, F., Cartenì, G., Caruso, M., Casadei, V., Casanova, C., Castori, L., Cavanna, L., Cavazzini, G., Cazzaniga, M., Chilelli, M., Chiodini, P., Chiorrini, S., Ciardiello, F., Ciccarese, M., Cinieri, S., Clerico, M., Coccaro, M., Comande, M., Corbo, C., Cortino, G., Cusenza, S., Daniele, G., D'arco, A. M., D'auria, G., Dazzi, C., De Angelis, C., de Braud, F., De Feo, G., De Matteis, A., De Tursi, M., Di Blasio, A., di Lucca, G., Di Lullo, L., Di Rella, F., Di Renzo, G., Di Stefano, P., Di Stefano, A., Diana, A., Donati, S., Fabbri, A., Fabi, A., Faedi, M., Farina, G., Farris, A., Febbraro, A., Fedele, P., Federico, P., Ferraù, F., Ferretti, G., Ferro, A., Floriani, I., Forcignanò, R., Forciniti, S., Forestieri, V., Fornari, G., Frisinghelli, M., Fusco, V., Gallizzi, G., Galvano, A., Gambardella, A., Gambi, A., Gebbia, V., Gervasi, E., Ghilardi, M., Giacobino, A., Giardina, G., Giotta, F., Giraudi, S., Giuliano, M., Grassadonia, A., Grasso, D., Grosso, F., Guizzaro, L., Incoronato, P., Incorvaia, L., Iodice, G., La Verde, N., Labonia, V., Landi, G., Latorre, A., Leonardi, V., Levaggi, A., Limite, G., Lina Bascialla, L., Livi, L., Maiello, E., Mandelli, D., Marcon, I., Menon, D., Montedoro, M., Moraca, L., Moretti, A., Morritti, M. G., Morselli, P., Mura, A., Mura, S., Musacchio, M., Muzio, A., Natale, D., Natoli, C., Nigro, C., Nisticò, C., Nuzzo, A., Orditura, M., Orlando, L., Pacilio, C., Palumbo, G., Palumbo, R., Pasini, F., Paterno, E., Pazzola, A., Pelliccioni, S., Pensabene, M., Perroni, D., Pesenti Gritti, A., Petrelli, F., Piccirillo, M. C., Pinotti, G., Pogliani, C., Poli, D., Prader, S., Recchia, F., Rizzi, D., Romano, C., Rossello, R., Rossini, C., Salvucci, G., Sanna, V., Santini, A., Saracchini, S., Savastano, C., Scambia, G., Schettini, F., Schiavone, P., Schirone, A., Seles, E., Signoriello, S., Signoriello, G., Silva, R. R., Silvestri, A., Simeon, V., Spagnoletti, I., Tamberi, S., Teragni, C., Thalmann, V., Thomas, R., Thomas, G., Tienghi, A., Tinari, N., Tinessa, V., Tomei, F., Tonini, G., Torri, V., Traficante, D., Tudini, M., Turazza, M., Vignoli, R., Vitale, M. G., Zacchia, A., Zagarese, P., Zanni, A., Zavallone, L., Zavettieri, M., Zoboli, A. & Investigators, GIM., 2018, In : The Lancet Oncology. 19, 4, p. 474-485 12 p.

Research output: Contribution to journalArticle

Adjuvant trastuzumab with docetaxel or vinorelbine for HER-2-positive breast cancer [1]

Ferretti, G., Papaldo, P., Fabi, A., Carlini, P., Felici, A. & Cognetti, F., 2006, In : The oncologist. 11, 7, p. 853-854 2 p.

Research output: Contribution to journalArticle

Ado-trastuzumab emtansine (T-DM1) in HER2+ advanced breast cancer patients: does pretreatment with pertuzumab matter?

Fabi, A., Giannarelli, D., Moscetti, L., Santini, D., Zambelli, A., Laurentiis, M. D., Caruso, M., Generali, D., Valle, E., Leonardi, V., Cannita, K., Arpino, G., Filippelli, G., Ferretti, G., Giampaglia, M., Montemurro, F., Nisticò, C., Gasparro, S. & Cognetti, F., Dec 2017, In : Future Oncology. 13, 30, p. 2791-2797 7 p.

Research output: Contribution to journalArticle

Ado-trastuzumab emtansine (T-DM1) in HER2+ advanced breast cancer patients: does pretreatment with pertuzumab matter?

Fabi, A., Giannarelli, D., Moscetti, L., Santini, D., Zambelli, A., Laurentiis, M. D., Caruso, M., Generali, D., Valle, E., Leonardi, V., Cannita, K., Arpino, G., Filippelli, G., Ferretti, G., Giampaglia, M., Montemurro, F., Nistico, C., Gasparro, S. & Cognetti, F., Dec 1 2017, In : Future Oncology. 13, p. 2791-2797 7 p.

Research output: Contribution to journalArticle

Alfa-epoietin and Anaemia in Gynaecological Cancer

Di Cocco, B., Salesi, N., Fabi, A., Nardoni, C., Ferretti, G., Bossone, G., Ciccarese, M., Savarese, A., Vecchione, A. & Cognetti, F., Mar 2004, In : Anticancer Research. 24, 2 C, p. 1287-1292 6 p.

Research output: Contribution to journalArticle

Alopecia in a premenopausal breast cancer woman treated with letrozole and triptorelin [1]

Carlini, P., Di Cosimo, S., Ferretti, G., Papaldo, P., Fabi, A., Ruggeri, E. M., Milella, M. & Cognetti, F., Nov 2003, In : Annals of Oncology. 14, 11, p. 1689-1690 2 p.

Research output: Contribution to journalArticle

A multicenter real-world study of bevacizumab in heavily pretreated malignant gliomas: Clinical benefit is a plausible end point?

Villani, V., Fabi, A., Tanzilli, A., Pasqualetti, F., Lombardi, G., Vidiri, A., Gonnelli, A., Molinari, A., Cantarella, M., Bellu, L., Terrenato, I., Carosi, M., Maschio, M., Telera, S. M., Carapella, C. M., Cognetti, F., Paiar, F., Zagonel, V. & Pace, A., May 2019, In : Future Oncology. 15, 15, p. 1717-1727 11 p.

Research output: Contribution to journalArticle

A multicenter real-world study of bevacizumab in heavily pretreated malignant gliomas: Clinical benefit is a plausible end point?

Villani, V., Fabi, A., Tanzilli, A., Pasqualetti, F., Lombardi, G., Vidiri, A., Gonnelli, A., Molinari, A., Cantarella, M., Bellu, L., Terrenato, I., Carosi, M., Maschio, M., Telera, S. M., Carapella, C. M., Cognetti, F., Paiar, F., Zagonel, V. & Pace, A., May 1 2019, In : Future Oncology. 15, 15, p. 1717-1727 11 p.

Research output: Contribution to journalArticle

Analysis of aneusomy level and HER-2 gene copy number and their effect on amplification rate in breast cancer specimens read as 2+ in immunohistochemical analysis

Merola, R., Mottolese, M., Orlandi, G., Vico, E., Cognetti, F., Sperduti, I., Fabi, A., Vitelli, G. & Cianciulli, A. M., Jul 2006, In : European Journal of Cancer. 42, 10, p. 1501-1506 6 p.

Research output: Contribution to journalArticle

An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) versus conventional paclitaxel for metastatic breast cancer patients: The COSTANza study

Lazzaro, C., Bordonaro, R., Cognetti, F., Fabi, A., De Placido, S., Arpino, G., Marchetti, P., Botticelli, A., Pronzato, P. & Martelli, E., Apr 9 2013, In : ClinicoEconomics and Outcomes Research. 5, 1, p. 125-135 11 p.

Research output: Contribution to journalArticle

Antitumor effects of clinical dosing regimens of bisphosphonates in experimental breast cancer bone metastasis

Ferretti, G., Fabi, A., Carlini, P., Papaldo, P., Felici, A. & Cognetti, F., Jul 2007, In : Bone. 41, 1, p. 155-156 2 p.

Research output: Contribution to journalArticle

An update on palonosetron hydrochloride for the treatment of radio/chemotherapy-induced nausea and vomiting

Fabi, A. & Malaguti, P., Apr 2013, In : Expert Opinion on Pharmacotherapy. 14, 5, p. 629-641 13 p.

Research output: Contribution to journalArticle

A phase II study on metastatic breast cancer patients treated with weekly vinorelbine with or without trastuzumab according to HER2 expression: Changing the natural history of HER2-positive disease

Papaldo, P., Fabi, A., Ferretti, G., Mottolese, M., Cianciulli, A. M., Di Cocco, B., Pino, M. S., Carlini, P., Di Cosimo, S., Sacchi, I., Sperduti, I., Nardoni, C. & Cognetti, F., Apr 2006, In : Annals of Oncology. 17, 4, p. 630-636 7 p.

Research output: Contribution to journalArticle

A phase II trial of vinorelbine and thiotepa in metastatic breast cancer

Fabi, A., Tonachella, R., Savarese, A., Cirulli, S., Tomao, S., Conte, E. & Cognetti, F., 1995, In : Annals of Oncology. 6, 2, p. 187-189 3 p.

Research output: Contribution to journalArticle

A predictive value of von Willebrand factor for early response to Bevacizumab therapy in recurrent glioma

Pace, A., Mandoj, C., Antenucci, A., Villani, V., Sperduti, I., Casini, B., Carosi, M., Fabi, A., Vidiri, A., Koudriavtseva, T. & Conti, L., Mar 28 2018, (Accepted/In press) In : Journal of Neuro-Oncology. p. 1-9 9 p.

Research output: Contribution to journalArticle

A randomized, double-blind, placebo-controlled, multicenter study of a ginger extract in the management of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high dose cisplatin

Bossi, P., Cortinovis, D., Fatigoni, S., Rocca, M. C., Fabi, A., Seminara, P., Ripamonti, C., Alfieri, S., Granata, R., Bergamini, C., Agustoni, F., Bidoli, P., Nole, F., Pessi, M. A., Macchi, F., Michellini, L., Montanaro, F. & Roila, F., Jun 28 2017, In : Annals of oncology : official journal of the European Society for Medical Oncology. 28, 10, p. 2547-2551

Research output: Contribution to journalArticle

A randomized, double-blind, placebo-controlled, multicenter study of a ginger extract in the management of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high-dose cisplatin

Bossi, P., Cortinovis, D., Fatigoni, S., Cossu Rocca, M., Fabi, A., Seminara, P., Ripamonti, C., Alfieri, S., Granata, R., Bergamini, C., Agustoni, F., Bidoli, P., Nolè, F., Pessi, M. A., Macchi, F., Michellini, L., Montanaro, F. & Roila, F., Oct 1 2017, In : Annals of oncology : official journal of the European Society for Medical Oncology. 28, 10, p. 2547-2551 5 p.

Research output: Contribution to journalArticle

A randomized, double-blind, placebo-controlled, multicenter study of a ginger extract in the management of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high-dose cisplatin

Bossi, P., Cortinovis, D., Fatigoni, S., Cossu Rocca, M., Fabi, A., Seminara, P., Ripamonti, C., Alfieri, S., Granata, R., Bergamini, C., Agustoni, F., Bidoli, P., Nolè, F., Pessi, M. A., Macchi, F., Michellini, L., Montanaro, F. & Roila, F., Jan 1 2017, In : Annals of Oncology. 28, 10, p. 2547-2551 5 p.

Research output: Contribution to journalArticle

A Real-World Multicentre Retrospective Study of Paclitaxel-Bevacizumab and Maintenance Therapy as First-Line for HER2-Negative Metastatic Breast Cancer

Gamucci, T., Mentuccia, L., Natoli, C., Sperduti, I., Cassano, A., Michelotti, A., Di Lauro, L., Sergi, D., Fabi, A., Sarobba, M. G., Marchetti, P., Barba, M., Magnolfi, E., Maugeri-Saccà, M., Rossi, E., Sini, V., Grassadonia, A., Pellegrini, D., Astone, A., Nisticò, C. & 11 others, Angelini, F., Vaccaro, A., Pellegrino, A., De Angelis, C., Palleschi, M., Moscetti, L., Bertolini, I., Buglioni, S., Giordano, A., Pizzuti, L. & Vici, P., Jun 2017, In : Journal of Cellular Physiology. 232, 6, p. 1571-1578 8 p.

Research output: Contribution to journalArticle

Aromatase inhibitors in post-menopausal metastatic breast carcinoma

Carlini, P., Bria, E., Giannarelli, D., Felici, A., Papaldo, P., Fabi, A., Ruggeri, E. M., Milella, M., Nuzzo, C., Cecere, F. L., Gelibter, A., Pino, M. S., Nisticò, C., Cuppone, F., Metro, G., Terzoli, E., Cognetti, F. & Ferretti, G., Jul 2007, In : Expert Opinion on Investigational Drugs. 16, 7, p. 1023-1036 14 p.

Research output: Contribution to journalArticle

Assessment of PTEN and PI3K status in primary breast cancer and corresponding metastases: Is it worthwhile?

Russillo, M., Di Benedetto, A., Metro, G., Ferretti, G., Papaldo, P., Cognetti, F., Mottolese, M. & Fabi, A., Jul 10 2011, In : Journal of Clinical Oncology. 29, 20, p. 2834-2835 2 p.

Research output: Contribution to journalArticle

Autoantibodies specific to estrogen receptor alpha act as estrogen agonists and their levels correlate with breast cancer cell proliferation

Maselli, A., Capoccia, S., Pugliese, P., Raggi, C., Cirulli, F., Fabi, A., Malorni, W., Pierdominici, M. & Ortona, E., Feb 2016, In : OncoImmunology. 5, 2, p. e1074375

Research output: Contribution to journalArticle

AVAREG: A phase II, randomized, noncomparative study of fotemustine or bevacizumab for patients with recurrent glioblastoma

Brandes, A., Finocchiaro, G., Zagonel, V., Reni, M., Caserta, C., Fabi, A., Clavarezza, M., Maiello, E., Eoli, M., Lombardi, G., Monteforte, M., Proietti, E., Agati, R., Eusebi, V. & Franceschi, E., Sep 1 2016, In : Neuro-Oncology. 18, 9, p. 1304-1312 9 p.

Research output: Contribution to journalArticle

AVAREG: A phase II, randomized, noncomparative study of fotemustine or bevacizumab for patients with recurrent glioblastoma

Brandes, A., Finocchiaro, G., Zagonel, V., Reni, M., Caserta, C., Fabi, A., Clavarezza, M., Maiello, E., Eoli, M., Lombardi, G., Monteforte, M., Proietti, E., Agati, R., Eusebi, V. & Franceschi, E., Sep 1 2016, In : Neuro-Oncology. 18, 9, p. 1304-1312 9 p.

Research output: Contribution to journalArticle

AVAREG: A phase II, randomized, noncomparative study of fotemustine or bevacizumab for patients with recurrent glioblastoma

Brandes, A. A., Finocchiaro, G., Zagonel, V., Reni, M., Caserta, C., Fabi, A., Clavarezza, M., Maiello, E., Eoli, M., Lombardi, G., Monteforte, M., Proietti, E., Agati, R., Eusebi, V. & Franceschi, E., Sep 1 2016, In : Neuro-Oncology. 18, 9, p. 1304-1312 9 p.

Research output: Contribution to journalArticle

AVAREG: A phase II, randomized, noncomparative study of fotemustine or bevacizumab for patients with recurrent glioblastoma

Brandes, A., Finocchiaro, G., Zagonel, V., Reni, M., Caserta, C., Fabi, A., Clavarezza, M., Maiello, E., Eoli, M., Lombardi, G., Monteforte, M., Proietti, E., Agati, R., Eusebi, V. & Franceschi, E., Sep 1 2016, In : Neuro-Oncology. 18, 9, p. 1304-1312 9 p.

Research output: Contribution to journalArticle

AVAREG: A phase II, randomized, noncomparative study of fotemustine or bevacizumab for patients with recurrent glioblastoma

Brandes, A., Finocchiaro, G., Zagonel, V., Reni, M., Caserta, C., Fabi, A., Clavarezza, M., Maiello, E., Eoli, M., Lombardi, G., Monteforte, M., Proietti, E., Agati, R., Eusebi, V. & Franceschi, E., Sep 1 2016, In : Neuro-Oncology. 18, 9, p. 1304-1312 9 p.

Research output: Contribution to journalArticle

Bone and lung metastases from intracranial meningioma

Fabi, A., Nuzzo, C., Vidiri, A., Ciccarese, M., Felici, A., Cattani, F. & Cognetti, F., Sep 2006, In : Anticancer Research. 26, 5 B, p. 3835-3837 3 p.

Research output: Contribution to journalArticle

Bone metastasis from glioblastoma multiforme without central nervous system relapse: A case report

Fabi, A., Vidiri, A., Carapella, C., Pace, A., Occhipinti, E., Caroli, F., Mirri, A., Carlini, P. & Cognetti, F., Jul 2004, In : Anticancer Research. 24, 4, p. 2563-2565 3 p.

Research output: Contribution to journalArticle

Bone of the hands as unusual metastastatic site of renal cell carcinoma

Salesi, N., Russillo, M., Marandino, F., Ruggeri, E. M., Metro, G., Cognetti, F. & Fabi, A., Dec 2007, In : Journal of Experimental and Clinical Cancer Research. 26, 4, p. 595-597 3 p.

Research output: Contribution to journalArticle

Brain metastases from solid tumors: Disease outcome according to type of treatment and therapeutic resources of the treating center

Fabi, A., Felici, A., Metro, G., Mirri, A., Bria, E., Telera, S., Moscetti, L., Russillo, M., Lanzetta, G., Mansueto, G., Pace, A., Maschio, M., Vidiri, A., Sperduti, I., Cognetti, F. & Carapella, C. M., 2011, In : Journal of Experimental and Clinical Cancer Research. 30, 1, 10.

Research output: Contribution to journalArticle

Brain radiotherapy during treatment with anticonvulsant therapy as a trigger for toxic epidermal necrolysis

Metro, G., Pino, S., Pellegrini, D., Sacerdoti, G. & Fabi, A., Mar 2007, In : Anticancer Research. 27, 2, p. 1167-1169 3 p.

Research output: Contribution to journalArticle

Breast cancer and timing of surgery during menstrual cycle: A 5-year analysis of 248 premenopausal women

Milella, M., Nisticò, C., Ferraresi, V., Vaccaro, A., Fabi, A., D'Ottavio, A. M., Botti, C., Giannarelli, D., Lopez, M., Cortesi, E., Foggi, C. M., Antimi, M., Terzoli, E., Cognetti, F. & Papaldo, P., 1999, In : Breast Cancer Research and Treatment. 55, 3, p. 259-266 8 p.

Research output: Contribution to journalArticle

Breast carcinomas with low amplified/equivocal HER2 by Ish: Potential supporting role of multiplex ligation-dependent probe amplification

Ercolani, C., Marchiò, C., Di Benedetto, A., Fabi, A., Perracchio, L., Vici, P., Sperati, F., Buglioni, S., Arena, V., Pescarmona, E., Sapino, A., Terrenato, I. & Mottolese, M., Oct 13 2017, In : Journal of Experimental and Clinical Cancer Research. 36, 1, 143.

Research output: Contribution to journalArticle

Breast carcinomas with low amplified/equivocal HER2 by Ish: potential supporting role of multiplex ligation-dependent probe amplification

Ercolani, C., Marchio, C., Benedetto, A. D., Fabi, A., Perracchio, L., Vici, P., Sperati, F., Buglioni, S., Arena, V., Pescarmona, E., Sapino, A., Terrenato, I. & Mottolese, M., Oct 13 2017, In : Journal of Experimental and Clinical Cancer Research. 36, 1, p. 143

Research output: Contribution to journalArticle

Can HER2 overexpression predict response to pegylated liposomal doxorubicin in metastatic breast cancer patients? [4]

Fabi, A., Ferretti, G., Salesi, N., Papaldo, P., Carlini, P., Ciccarese, M., Di Cocco, B., Cecere, F., Nardoni, C., Felici, A. & Cognetti, F., Mar 2005, In : Annals of Oncology. 16, 3, p. 516-517 2 p.

Research output: Contribution to journalArticle

Carcinoma della mammella maschile: Sei anni di esperienza

Translated title of the contribution: Male breast cancer: 6-year experienceLa Pinta Massimo, M., Fabi, A., Ascarelli, A., Ponzani, T., Di Carlo, V., Scicchitano, F., Saputo, S., Russillo, M. & Andrich, R., Apr 2008, In : Minerva Chirurgica. 63, 2, p. 71-78 8 p.

Research output: Contribution to journalArticle

Catheter-associated thrombosis: Thromboprophylaxis for cancer patients who carry factor V Leiden? [3]

Ferretti, G., Bria, E., Felici, A., Carlini, P., Giannarelli, D., Ciccarese, M., Papaldo, P., Fabi, A., Gelibter, A. & Cognetti, F., Mar 2006, In : Annals of Oncology. 17, 3, p. 528-529 2 p.

Research output: Contribution to journalArticle

CEREBEL (EGF111438): A phase III, randomized, open-label study of lapatinib plus capecitabine versus trastuzumab plus capecitabine in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer

Pivot, X., Manikhas, A., Zurawski, B., Chmielowska, E., Karaszewska, B., Allerton, R., Chan, S., Fabi, A., Bidoli, P., Gori, S., Ciruelos, E., Dank, M., Hornyak, L., Margolin, S., Nusch, A., Parikh, R., Nagi, F., DeSilvio, M., Santillana, S., Swaby, R. F. & 1 others, Semiglazov, V., May 10 2015, In : Journal of Clinical Oncology. 33, 14, p. 1564-1573 10 p.

Research output: Contribution to journalArticle

Chemotherapy-induced amenorrhea in early breast cancer [4]

Ferretti, G., Carlini, P., Bria, E., Felici, A., Giannarelli, D., Ciccarese, M., Papaldo, P., Fabi, A. & Cognetti, F., Feb 2006, In : Annals of Oncology. 17, 2, p. 352 1 p.

Research output: Contribution to journalArticle

Chemotherapy in neoplastic meningitis

Pace, A. & Fabi, A., Dec 2006, In : Critical Reviews in Oncology/Hematology. 60, 3, p. 194-200 7 p.

Research output: Contribution to journalArticle

Choroid plexus carcinoma in the adult: Is there a role for chemotherapy?

Fabi, A., Salesi, N., Di Cocco, B., Vidiri, A., Visca, P., Pace, A., Carapella, C., De Paula, U., Mirri, A. & Cognetti, F., Sep 2005, In : Journal of Experimental and Clinical Cancer Research. 24, 3, p. 493-496 4 p.

Research output: Contribution to journalArticle

Cisplatin and escalating doses of paclitaxel and epirubicin in advanced ovarian cancer. A phase I study

Nardi, M., De Marco, S., Fabi, A., Aloe, A., Magnani, E., Pacetti, U., Carlini, P., Ruggeri, E. M. & Cognetti, F., 2001, In : Cancer Chemotherapy and Pharmacology. 48, 3, p. 255-258 4 p.

Research output: Contribution to journalArticle